Velos Investigational Drug System Doubles Install Base in One Year

FREMONT, CALIFORNIA – July 26, 2018 Velos, Inc., a clinical research management software vendor, is pleased to announce impressive growth of the company’s Investigational Drug Management System through continued product innovation. In one year alone, Velos Investigational Drug System (Velos IDS) has doubled its customer base. The product is now being used to manage drug […]

Read More

Velos Spring analytics platform for clinical research rolls out with a collaborative approach

FREMONT, CALIFORNIA – July 10, 2018 Velos, Inc., a market leader in clinical research management software, is rolling out its Velos Spring analytics platform for clinical research with a collaborative approach. Velos, Inc. is a market leader in clinical research management software for clinical research sites. Healthcare organizations using Velos products receive approximately 50% of […]

Read More

Velos Annual Meeting “Best Yet”

FREMONT, CA – June 5, 2018 Velos held its 14th annual customer meeting on May 7th and 8th, 2018, in Fremont, California. Clinical research professionals from Velos customer organizations across the United States and internationally gathered to share their experiences, learn about new products and product features, and collaborate. Long-time Velos eResearch customers who have […]

Read More

Major Velos product and services investments drive customer growth

FREMONT, CA – March 16, 2018 Velos continues to add a diversity of new customers at an increasing pace. Recent wins include the largest academic medical research network in the world; a clinical data research consortium that includes specialty units in 35 academic medical centers and health systems; two hospital chains with over sixty cumulative […]

Read More

Velos Communications – Terumo BCT Partners with StafaCT

Fremont, CA – March 8, 2018 Velos is pleased to announce that Terumo BCT is now StafaCT’s partner in Apheresis, Cell Therapy, and Transplant. StafaCT is the Velos subsidiary focused on software for cell therapy. This collaboration was announced on February 24 at the Bone Marrow Transplant (BMT) Tandem 2018 conference, which is jointly hosted […]

Read More

Major new Velos eCompliance release deepens Velos product line for clinical researchers

FREMONT, CA – March 2, 2018 Version 10 of Velos eCompliance is a major new software release that simplifies complex workflows and processes for Institutional Review Boards (IRBs), Protocol Review Committees(PRCs), and departmental reviews. Velos eCompliance is part of the Velos eResearch software family many regard as the most integrated, comprehensive, and advanced software solution […]

Read More

Velos successfully leads efforts to centralize clinical research management across borders

FREMONT, CA – Oct 04, 2017 Velos, Inc. has recently emerged as the leading software vendor for multi-center, multi-trial clinical research management. The company’s flagship clinical research management system, Velos eResearch, now connects hundreds of care locations and thousands of physicians at premier healthcare institutions, large not-for-profit healthcare systems, prestigious cancer centers, and research institutions […]

Read More

2017 Velos Annual Meeting: Leading-Edge Technologies Continue to Transform Research in the Healthcare Industry

FREMONT, CA – May 25, 2017 Velos, Inc. and its customers showcased leading-edge technological advancements with high impact on clinical research at the 2017 Velos Annual Meeting from April 10-12 in Fremont, California. Organized around presentations, panels, and workshops, the conference provided a collaborative forum for industry leaders, academic institutions, and hospital networks, to discuss […]

Read More

Velos CRMS adds over 50 new research sites

FREMONT, CA – Feb 28, 2017 Velos, Inc. has added over 50 new research sites to its Velos eResearch customer base in less than one year. The large increase in both customers and sites is attributable in part to the company’s unique strengths in addressing the needs of multi-site clinical trial networks. The company’s substantial […]

Read More
Page 1 of 512345